MALT1 is an intracellular signaling protein capable of activating both innate immune cells, including natural killer (NK) cells, dendritic cells, and mast cells, as well as adaptive immune cells such as T and B cells. MALT1 is best known for its function in mediating T cell activation and proliferation. Deregulation of MALT1 is implicated in a number of T and B cell malignancies, including leukemias and lymphomas, as well as specific autoimmune inflammatory diseases and select carcinomas and solid tumors, making it a prominent target for treating a wide variety of diseases.